Objective: This scoping review aims to map and characterize the integration of One Health competencies into medical curricula, along with the associated outcomes, challenges, and supporting factors.
Introduction: Equipping future health professionals with One Health competencies is crucial amid ongoing health threats at the human-animal-environment interface. Addressing these challenges requires multidisciplinary collaboration, yet medical education lags behind other fields in integrating One Health, limiting awareness and readiness for interprofessional work beyond the human health sector. The extent of One Health integration into medical curricula remains unevaluated.
Eligibility criteria: This scoping review will include both published and unpublished research, as well as non-research articles, that describe/evaluate courses, modules, or learning activities designed to develop One Health competencies within undergraduate or postgraduate medical curricula. These initiatives must engage medical students, residents, or both, either exclusively or alongside students from other disciplines. This review will include sources in any language from 2008 onward. Sources reporting continuing professional development, extracurricular activities, educational outcomes, implementation challenges, and supporting factors in general terms will be excluded.
Methods: This review follows the JBI methodology for scoping reviews. Searches will be conducted in PubMed (including MEDLINE), Scopus, Web of Science, ERIC (ProQuest), SpringerLink, and will include gray literature sources, such as Google, Google Scholar, thesis repositories, and One Health University network websites. Two reviewers will independently screen sources and extract data following a pilot test for each stage. Analysis will include frequency counts, thematic analysis, competency mapping, and evidence synthesis using a logic model.
Review registration: OSF https://osf.io/gt3ru.
目的:本综述旨在绘制和描述将“一体健康”能力整合到医学课程中的过程,以及相关的结果、挑战和支持因素。在人类-动物-环境界面的持续健康威胁中,为未来的卫生专业人员配备“同一个健康”能力至关重要。应对这些挑战需要多学科合作,但医学教育在整合“同一健康”方面落后于其他领域,限制了对人类卫生部门以外跨专业工作的认识和准备。“同一个健康”纳入医学课程的程度仍未得到评估。资格标准:本次范围审查将包括已发表和未发表的研究,以及描述/评估本科或研究生医学课程中旨在培养“同一个健康”能力的课程、模块或学习活动的非研究文章。这些举措必须让医学生、住院医生或两者都参与进来,要么单独参与,要么与其他学科的学生一起参与。此审查将包括2008年以后的任何语言的来源。一般而言,关于持续专业发展、课外活动、教育成果、实施挑战和支持因素的来源将被排除在外。方法:本综述遵循JBI方法进行范围综述。检索将在PubMed(包括MEDLINE)、Scopus、Web of Science、ERIC (ProQuest)、SpringerLink中进行,并将包括灰色文献来源,如谷歌、谷歌Scholar、论文库和One Health University网络网站。两名审稿人将独立筛选来源并在每个阶段的试点测试后提取数据。分析将包括频率计数、专题分析、能力映射和使用逻辑模型的证据合成。评审注册:OSF https://osf.io/gt3ru。
{"title":"Integration of One Health competencies in medical curricula: a scoping review protocol.","authors":"Dian Puspita Sari, Yoga Pamungkas Susani, Gandes Retno Rahayu","doi":"10.11124/JBIES-25-00147","DOIUrl":"10.11124/JBIES-25-00147","url":null,"abstract":"<p><strong>Objective: </strong>This scoping review aims to map and characterize the integration of One Health competencies into medical curricula, along with the associated outcomes, challenges, and supporting factors.</p><p><strong>Introduction: </strong>Equipping future health professionals with One Health competencies is crucial amid ongoing health threats at the human-animal-environment interface. Addressing these challenges requires multidisciplinary collaboration, yet medical education lags behind other fields in integrating One Health, limiting awareness and readiness for interprofessional work beyond the human health sector. The extent of One Health integration into medical curricula remains unevaluated.</p><p><strong>Eligibility criteria: </strong>This scoping review will include both published and unpublished research, as well as non-research articles, that describe/evaluate courses, modules, or learning activities designed to develop One Health competencies within undergraduate or postgraduate medical curricula. These initiatives must engage medical students, residents, or both, either exclusively or alongside students from other disciplines. This review will include sources in any language from 2008 onward. Sources reporting continuing professional development, extracurricular activities, educational outcomes, implementation challenges, and supporting factors in general terms will be excluded.</p><p><strong>Methods: </strong>This review follows the JBI methodology for scoping reviews. Searches will be conducted in PubMed (including MEDLINE), Scopus, Web of Science, ERIC (ProQuest), SpringerLink, and will include gray literature sources, such as Google, Google Scholar, thesis repositories, and One Health University network websites. Two reviewers will independently screen sources and extract data following a pilot test for each stage. Analysis will include frequency counts, thematic analysis, competency mapping, and evidence synthesis using a logic model.</p><p><strong>Review registration: </strong>OSF https://osf.io/gt3ru.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayank Khandelwal, Karthik Sennimalai, O P Kharbanda, Denny John
Objective: This review will investigate the effectiveness of nasoalveolar molding (NAM) in patients with non-syndromic bilateral cleft lip and palate (BCLP), compared to no intervention in patients with non-syndromic BCLP, patients with non-syndromic unilateral cleft lip and palate (UCLP), and non-cleft control subjects, in producing morphological changes of the lip, nose, and occlusion, evaluated after a minimum follow-up period of 2 years.
Introduction: Nasoalveolar molding offers benefits in managing cleft patients; however, concerns include hindrance to jaw growth, malocclusion, and soft tissue effects.
Eligibility criteria: Randomized and non-randomized studies evaluating the long-term (minimum follow-up of 2 years after primary cleft lip repair surgery) soft tissue, dental, and skeletal effects of NAM in non-syndromic BCLP patients compared to non-syndromic BCLP patients not undergoing NAM, non-syndromic UCLP patients who underwent NAM, and non-cleft control subjects.
Methods: The review will follow the JBI methodology for systematic review of effectiveness. PubMed, Scopus, Embase (Ovid), VHL Regional Portal (including LILACS), Web of Science Core Collection, Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, ProQuest Health and Medical Collection, MedNar, OpenGrey, and ClinicalTrials.gov will be searched for published and unpublished literature, in any language. Two independent reviewers will screen the titles/abstracts and full-texts. Critical appraisal will be conducted using the standard JBI appraisal tools. Meta-analysis will be conducted for all outcomes where appropriate, with weighted mean differences for continuous data, and risk ratios will be used for dichotomous data. Certainty of the evidence will be reported using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
Prospero id: CRD42024510757.
目的:本综述将探讨鼻肺泡成型(NAM)在非综合征性双侧唇腭裂(BCLP)患者中的有效性,与非综合征性双侧唇腭裂(BCLP)患者、非综合征性单侧唇腭裂(UCLP)患者和非唇腭裂对照组相比,在唇、鼻和咬合形态改变方面的效果,至少随访2年。介绍:鼻牙槽成型提供治疗腭裂患者的好处;然而,担心包括颌骨生长障碍,错颌和软组织的影响。入选标准:随机和非随机研究,评估非综合征性BCLP患者与未行非综合征性BCLP患者、行非综合征性UCLP患者和非唇裂对照组相比,非综合征性BCLP患者的软组织、牙齿和骨骼的长期影响(原发性唇裂修复手术后至少随访2年)。方法:采用JBI方法对疗效进行系统评价。PubMed、Scopus、Embase (Ovid)、VHL区域门户网站(包括LILACS)、Web of Science核心收藏、Cochrane中央对照试验注册中心(Central)、谷歌Scholar、ProQuest健康与医疗收藏、MedNar、OpenGrey和ClinicalTrials.gov将被搜索到任何语言的已发表和未发表的文献。两位独立审稿人将对标题/摘要和全文进行筛选。关键评估将使用标准的JBI评估工具进行。在适当的情况下,将对所有结果进行荟萃分析,对连续数据采用加权平均差异,对二分类数据采用风险比。证据的确定性将使用建议、评估、发展和评价分级(GRADE)方法进行报告。普洛斯彼罗id: CRD42024510757。
{"title":"Long-term effects of nasoalveolar molding in non-syndromic bilateral cleft lip and palate patients: a systematic review protocol.","authors":"Mayank Khandelwal, Karthik Sennimalai, O P Kharbanda, Denny John","doi":"10.11124/JBIES-24-00487","DOIUrl":"10.11124/JBIES-24-00487","url":null,"abstract":"<p><strong>Objective: </strong>This review will investigate the effectiveness of nasoalveolar molding (NAM) in patients with non-syndromic bilateral cleft lip and palate (BCLP), compared to no intervention in patients with non-syndromic BCLP, patients with non-syndromic unilateral cleft lip and palate (UCLP), and non-cleft control subjects, in producing morphological changes of the lip, nose, and occlusion, evaluated after a minimum follow-up period of 2 years.</p><p><strong>Introduction: </strong>Nasoalveolar molding offers benefits in managing cleft patients; however, concerns include hindrance to jaw growth, malocclusion, and soft tissue effects.</p><p><strong>Eligibility criteria: </strong>Randomized and non-randomized studies evaluating the long-term (minimum follow-up of 2 years after primary cleft lip repair surgery) soft tissue, dental, and skeletal effects of NAM in non-syndromic BCLP patients compared to non-syndromic BCLP patients not undergoing NAM, non-syndromic UCLP patients who underwent NAM, and non-cleft control subjects.</p><p><strong>Methods: </strong>The review will follow the JBI methodology for systematic review of effectiveness. PubMed, Scopus, Embase (Ovid), VHL Regional Portal (including LILACS), Web of Science Core Collection, Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, ProQuest Health and Medical Collection, MedNar, OpenGrey, and ClinicalTrials.gov will be searched for published and unpublished literature, in any language. Two independent reviewers will screen the titles/abstracts and full-texts. Critical appraisal will be conducted using the standard JBI appraisal tools. Meta-analysis will be conducted for all outcomes where appropriate, with weighted mean differences for continuous data, and risk ratios will be used for dichotomous data. Certainty of the evidence will be reported using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.</p><p><strong>Prospero id: </strong>CRD42024510757.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R Rajalakshmi, M Kavya, Swapna Nayak, Shruthi Bhandarkar, Jayaraj Mymbilly Balakrishnan, Sreedharan Nair, Sohil Khan, Karattuthodi Mohammed Salim, Sneh Shalini, R Uday Kumar, N V Vajid, Girish Thunga
Objective: The objective of this review is to synthesize qualitative evidence on the perceptions of health care professionals and policymakers regarding barriers and facilitators to implementing antimicrobial stewardship (AMS) programs in hospital settings, particularly in low- and middle-income countries.
Introduction: AMS programs are widely recognized as critical interventions to combat antimicrobial resistance and optimize the use of antibiotics. While quantitative studies have demonstrated the effectiveness of AMS programs in reducing inappropriate antibiotic use, less is known about the experiences, perceptions, and contextual factors that influence their implementation and sustainability.
Eligibility criteria: This review will include qualitative studies exploring the experiences, perceptions, attitudes, and contextual factors influencing implementation of AMS programs among health care professionals and policymakers. Studies conducted in any health care setting and involving any population relevant to AMS programs will be considered.
Methods: The key information sources to be searched for this review include PubMed, CINAHL (EBSCOhost), PsycINFO (Ovid), Scopus, Embase (Elsevier), and Web of Science. The search will include studies published in any language from 2015 onwards. Study selection will be conducted independently by 2 reviewers, with any disagreements resolved through discussion or consultation with a third reviewer. All included studies will be critically appraised for methodological quality, and only those meeting a predefined threshold will proceed to synthesis. Data relevant to the review objectives will be extracted, followed by an aggregative data synthesis approach. Confidence in the findings will be assessed using a structured grading process based on credibility and dependability.
Review registration: PROSPERO CRD420251044164.
目的:本综述的目的是综合定性证据,了解卫生保健专业人员和政策制定者对医院环境中实施抗菌药物管理(AMS)计划的障碍和促进因素的看法,特别是在低收入和中等收入国家。导言:AMS项目被广泛认为是对抗抗菌素耐药性和优化抗生素使用的关键干预措施。虽然定量研究已经证明了AMS项目在减少不当抗生素使用方面的有效性,但对影响其实施和可持续性的经验、观念和背景因素的了解却很少。资格标准:本综述将包括定性研究,探讨经验,观念,态度,以及影响医疗保健专业人员和政策制定者实施辅助医疗辅助计划的背景因素。在任何卫生保健环境中进行的研究,涉及与辅助医疗服务计划相关的任何人群,都将被考虑。方法:检索主要信息源包括PubMed、CINAHL (EBSCOhost)、PsycINFO (Ovid)、Scopus、Embase (Elsevier)和Web of Science。搜索将包括2015年以后以任何语言发表的研究。研究选择将由2名审稿人独立进行,任何分歧应通过与第三名审稿人讨论或协商解决。所有纳入的研究都将对方法学质量进行严格评价,只有那些达到预定义阈值的研究才会进行综合。将提取与审查目标有关的数据,然后采用综合数据综合方法。对调查结果的信心将采用基于可信度和可靠性的结构化分级程序进行评估。审核注册:PROSPERO CRD420251044164。
{"title":"Perspectives of health care professionals and policymakers on antimicrobial stewardship and implementation challenges in low- and middle-income country hospital settings: a qualitative systematic review protocol.","authors":"R Rajalakshmi, M Kavya, Swapna Nayak, Shruthi Bhandarkar, Jayaraj Mymbilly Balakrishnan, Sreedharan Nair, Sohil Khan, Karattuthodi Mohammed Salim, Sneh Shalini, R Uday Kumar, N V Vajid, Girish Thunga","doi":"10.11124/JBIES-25-00203","DOIUrl":"https://doi.org/10.11124/JBIES-25-00203","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this review is to synthesize qualitative evidence on the perceptions of health care professionals and policymakers regarding barriers and facilitators to implementing antimicrobial stewardship (AMS) programs in hospital settings, particularly in low- and middle-income countries.</p><p><strong>Introduction: </strong>AMS programs are widely recognized as critical interventions to combat antimicrobial resistance and optimize the use of antibiotics. While quantitative studies have demonstrated the effectiveness of AMS programs in reducing inappropriate antibiotic use, less is known about the experiences, perceptions, and contextual factors that influence their implementation and sustainability.</p><p><strong>Eligibility criteria: </strong>This review will include qualitative studies exploring the experiences, perceptions, attitudes, and contextual factors influencing implementation of AMS programs among health care professionals and policymakers. Studies conducted in any health care setting and involving any population relevant to AMS programs will be considered.</p><p><strong>Methods: </strong>The key information sources to be searched for this review include PubMed, CINAHL (EBSCOhost), PsycINFO (Ovid), Scopus, Embase (Elsevier), and Web of Science. The search will include studies published in any language from 2015 onwards. Study selection will be conducted independently by 2 reviewers, with any disagreements resolved through discussion or consultation with a third reviewer. All included studies will be critically appraised for methodological quality, and only those meeting a predefined threshold will proceed to synthesis. Data relevant to the review objectives will be extracted, followed by an aggregative data synthesis approach. Confidence in the findings will be assessed using a structured grading process based on credibility and dependability.</p><p><strong>Review registration: </strong>PROSPERO CRD420251044164.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amanda Hlushak, Michelle Kidd, Jason Bendall, Kingsley Agho, Robin Pap, Paul Simpson
Objective: The objective of this scoping review will be to map the evidence on the non-transport of patients following paramedic assessment and care, focusing on patient characteristics, decision-making processes, and associated patient outcomes.
Introduction: Patients with low-acuity or non-urgent concerns are frequently encountered by paramedics and ambulance service clinicians. Traditionally, paramedics provide assessment and care to out-of-hospital patients, followed by transport to the emergency department (ED). However, many of these non-urgent or low-acuity presentations may be more appropriate for referral to non-ED health care services. There is currently little research on the safety of non-urgent patients and their clinical outcomes when these patients are not transported to hospital.
Eligibility criteria: This review will consider studies of any methodology relating to patients who have been assessed by and received care from paramedics working within an ambulance service context and who are not subsequently transported to ED. Due to inconsistency in terminology between jurisdictions, the term paramedic will be used throughout the review, but evidence that uses other terms such as emergency medical technician or advanced care paramedic will also be eligible.
Methods: This review will follow the JBI methodology for scoping reviews and will be reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The following databases will be searched: MEDLINE (Ovid), CINAHL (EBSCOhost), Embase (EBSCOhost), JBI Evidence Synthesis, Cochrane Database of Systematic Reviews, and Scopus. Gray literature will also be searched for. Two reviewers will conduct the searches, title and abstract screening, full-text screening, and data extraction. The results will be presented in tabular format, accompanied by a narrative description.
目的:这一范围审查的目的将是绘制在护理人员评估和护理后非转移患者的证据,重点关注患者特征、决策过程和相关的患者结果。低视力或非紧急问题的患者经常遇到护理人员和救护车服务临床医生。传统上,护理人员为院外病人提供评估和护理,然后将其运送到急诊科。然而,许多这些非紧急或低视力的表现可能更适合转诊到非急诊科的卫生保健服务。目前关于非紧急患者的安全性及其未被送往医院时的临床结果的研究很少。资格标准:本综述将考虑与在救护车服务环境中接受护理人员评估并接受护理的患者相关的任何方法学研究,这些患者随后未被送往急诊科。由于司法管辖区之间的术语不一致,整个综述将使用护理人员一词,但使用其他术语(如紧急医疗技术人员或高级护理护理人员)的证据也将符合条件。方法:本综述将遵循JBI方法进行范围评价,并将按照系统评价和荟萃分析扩展范围评价(PRISMA-ScR)指南的首选报告项目进行报告。将检索以下数据库:MEDLINE (Ovid)、CINAHL (EBSCOhost)、Embase (EBSCOhost)、JBI Evidence Synthesis、Cochrane system Reviews Database和Scopus。灰色文献也将被搜索。两名审稿人将进行检索、标题和摘要筛选、全文筛选和数据提取。结果将以表格形式提出,并附有叙述性说明。评审注册:OSF https://doi.org/10.17605/OSF.IO/C9SNB。
{"title":"Non-transport of patients following assessment and care by paramedics: a scoping review protocol.","authors":"Amanda Hlushak, Michelle Kidd, Jason Bendall, Kingsley Agho, Robin Pap, Paul Simpson","doi":"10.11124/JBIES-24-00485","DOIUrl":"https://doi.org/10.11124/JBIES-24-00485","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this scoping review will be to map the evidence on the non-transport of patients following paramedic assessment and care, focusing on patient characteristics, decision-making processes, and associated patient outcomes.</p><p><strong>Introduction: </strong>Patients with low-acuity or non-urgent concerns are frequently encountered by paramedics and ambulance service clinicians. Traditionally, paramedics provide assessment and care to out-of-hospital patients, followed by transport to the emergency department (ED). However, many of these non-urgent or low-acuity presentations may be more appropriate for referral to non-ED health care services. There is currently little research on the safety of non-urgent patients and their clinical outcomes when these patients are not transported to hospital.</p><p><strong>Eligibility criteria: </strong>This review will consider studies of any methodology relating to patients who have been assessed by and received care from paramedics working within an ambulance service context and who are not subsequently transported to ED. Due to inconsistency in terminology between jurisdictions, the term paramedic will be used throughout the review, but evidence that uses other terms such as emergency medical technician or advanced care paramedic will also be eligible.</p><p><strong>Methods: </strong>This review will follow the JBI methodology for scoping reviews and will be reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The following databases will be searched: MEDLINE (Ovid), CINAHL (EBSCOhost), Embase (EBSCOhost), JBI Evidence Synthesis, Cochrane Database of Systematic Reviews, and Scopus. Gray literature will also be searched for. Two reviewers will conduct the searches, title and abstract screening, full-text screening, and data extraction. The results will be presented in tabular format, accompanied by a narrative description.</p><p><strong>Review registration: </strong>OSF https://doi.org/10.17605/OSF.IO/C9SNB.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dipak K Das, Samyukta Shivshankar, Atul M Budukh, Denny John
Objective: This systematic review will examine the association between pesticide use and cancer incidence among farm workers.
Introduction: Farmers are the most essential part of many countries' agriculture-based economies. Several studies have identified acute and chronic hazards associated with pesticide use, including lymphoma, leukemia, brain tumors and other cancers. However, no systematic reviews have comprehensively assessed the association between pesticide use and cancer incidence among farmers.
Eligibility criteria: Primary observational studies (case-control, cohort, and cross-sectional) that include participants who are farm workers (farmers, their spouses, and seasonal workers) in any geographic location and that document exposure to pesticides associated with cancer incidence will be eligible for inclusion.
Methods: Academic databases (PubMed, Web of Science Core Collection, Ovid Embase, Cochrane CENTRAL, and ProQuest Health and Medical Collection), non-academic databases (Google Scholar up to 20 pages), and other gray literature (OAIster, Shodhganga, and medRxiv) will be searched. Two reviewers will independently screen titles/abstracts and full texts, with adjudication by a third reviewer. Critical appraisal of the included studies will be performed using JBI checklists. Quantitative outcomes on the association of pesticide exposure and cancer incidence will be pooled in statistical meta-analysis, where possible. Heterogeneity between studies will be assessed statistically using standard χ2 and I2 tests. Where statistical pooling is not possible, the findings will be presented narratively. Certainty of the evidence regarding the carcinogenicity of pesticides will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.
Review registration: PROSPERO CRD420251019979.
目的:本系统综述将探讨农药使用与农业工人癌症发病率之间的关系。导言:农民是许多国家以农业为基础的经济中最重要的组成部分。一些研究已经确定了与农药使用有关的急性和慢性危害,包括淋巴瘤、白血病、脑肿瘤和其他癌症。然而,没有系统的综述全面评估农药使用与农民癌症发病率之间的关系。入选标准:主要观察性研究(病例对照、队列研究和横断面研究)包括任何地理位置的农场工人(农民、其配偶和季节工),并记录农药暴露与癌症发病率相关的研究均符合入选条件。方法:将检索学术数据库(PubMed、Web of Science Core Collection、Ovid Embase、Cochrane CENTRAL和ProQuest Health and Medical Collection)、非学术数据库(b谷歌Scholar最多20页)和其他灰色文献(OAIster、Shodhganga和medRxiv)。两名审稿人将独立筛选标题/摘要和全文,由第三名审稿人进行评审。将使用JBI检查表对纳入的研究进行批判性评估。在可能的情况下,农药暴露与癌症发病率之间关系的定量结果将汇总在统计荟萃分析中。采用标准χ2和I2检验对研究间的异质性进行统计评估。如果统计汇集是不可能的,调查结果将叙述。有关农药致癌性证据的确定性将采用建议、评估、发展和评估分级(GRADE)方法进行评估。评审注册号:PROSPERO CRD420251019979。
{"title":"Association between pesticide use and cancer incidence among farm workers: a systematic review protocol.","authors":"Dipak K Das, Samyukta Shivshankar, Atul M Budukh, Denny John","doi":"10.11124/JBIES-25-00177","DOIUrl":"https://doi.org/10.11124/JBIES-25-00177","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review will examine the association between pesticide use and cancer incidence among farm workers.</p><p><strong>Introduction: </strong>Farmers are the most essential part of many countries' agriculture-based economies. Several studies have identified acute and chronic hazards associated with pesticide use, including lymphoma, leukemia, brain tumors and other cancers. However, no systematic reviews have comprehensively assessed the association between pesticide use and cancer incidence among farmers.</p><p><strong>Eligibility criteria: </strong>Primary observational studies (case-control, cohort, and cross-sectional) that include participants who are farm workers (farmers, their spouses, and seasonal workers) in any geographic location and that document exposure to pesticides associated with cancer incidence will be eligible for inclusion.</p><p><strong>Methods: </strong>Academic databases (PubMed, Web of Science Core Collection, Ovid Embase, Cochrane CENTRAL, and ProQuest Health and Medical Collection), non-academic databases (Google Scholar up to 20 pages), and other gray literature (OAIster, Shodhganga, and medRxiv) will be searched. Two reviewers will independently screen titles/abstracts and full texts, with adjudication by a third reviewer. Critical appraisal of the included studies will be performed using JBI checklists. Quantitative outcomes on the association of pesticide exposure and cancer incidence will be pooled in statistical meta-analysis, where possible. Heterogeneity between studies will be assessed statistically using standard χ2 and I2 tests. Where statistical pooling is not possible, the findings will be presented narratively. Certainty of the evidence regarding the carcinogenicity of pesticides will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.</p><p><strong>Review registration: </strong>PROSPERO CRD420251019979.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146114343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Georgia Mae Willcox, Dorothy Agnes Shead, Busisiwe Constance Maseko
Objectives: The aim of this scoping review is to map the existing information on the characteristics of the use of complementary or alternative medicine (CAM) as treatment for the signs and symptoms of autism spectrum disorder (ASD).
Introduction: ASD is a neurodevelopmental disorder marked by social-communication difficulties and restrictive, repetitive behaviors resulting from complex interactions of genetic and environmental factors, and associated with psychological and medical comorbidities. It is a global phenomenon with a detrimental impact on families. Supplemental to conventional treatments care givers can consider using CAM.
Eligibility criteria: Primary, secondary, and gray literature sources considering the use of CAM for ASD will be included. Sources proposing the use of CAM for any condition other than ASD or discussing any therapy for ASD other than CAM will be excluded. Studies in all languages will be considered for inclusion, as will sources from the last decade (2015-2025).
Methods: This scoping review will be conducted in line with the JBI scoping review framework and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A primary search of PubMed to identify keywords and phrases will be followed by subsequent searches of Emcare (Ovid), Nursing and Allied Health Premium (ProQuest), Scopus, and Google Scholar. The titles, abstracts, and full texts of identified sources will be screened for relevancy by 2 independent reviewers, with conflicts adjudicated by a third reviewer. Findings will be discussed in a narrative summary and illustrated using figures, tables, and a gap map.
目的:这一范围审查的目的是绘制关于使用补充或替代医学(CAM)作为治疗自闭症谱系障碍(ASD)体征和症状的特征的现有信息。简介:ASD是一种神经发育障碍,以社交困难和限制性、重复性行为为特征,是遗传和环境因素复杂相互作用的结果,并伴有心理和医学合并症。这是一种对家庭产生有害影响的全球现象。作为常规治疗的补充,护理人员可以考虑使用辅助辅助治疗。入选标准:将包括考虑使用CAM治疗ASD的主要、次要和灰色文献来源。建议将CAM用于除ASD以外的任何病症或讨论除CAM以外的任何ASD治疗的来源将被排除在外。所有语言的研究都将被纳入考虑范围,过去十年(2015-2025年)的研究也将纳入考虑范围。方法:该范围评价将按照JBI范围评价框架进行,并使用范围评价系统评价和荟萃分析扩展首选报告项目(PRISMA-ScR)进行报告。首先搜索PubMed以确定关键字和短语,随后搜索Emcare (Ovid)、Nursing and Allied Health Premium (ProQuest)、Scopus和谷歌Scholar。确定来源的标题、摘要和全文将由2名独立审稿人筛选相关性,冲突由第三名审稿人裁决。研究结果将以叙述性摘要的形式进行讨论,并使用图表、表格和差距图进行说明。评审注册:OSF https://osf.io/c9j5n/overview。
{"title":"Global characteristics of the use of complementary and alternative medicine for autism spectrum disorder: a scoping review protocol.","authors":"Georgia Mae Willcox, Dorothy Agnes Shead, Busisiwe Constance Maseko","doi":"10.11124/JBIES-25-00264","DOIUrl":"https://doi.org/10.11124/JBIES-25-00264","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this scoping review is to map the existing information on the characteristics of the use of complementary or alternative medicine (CAM) as treatment for the signs and symptoms of autism spectrum disorder (ASD).</p><p><strong>Introduction: </strong>ASD is a neurodevelopmental disorder marked by social-communication difficulties and restrictive, repetitive behaviors resulting from complex interactions of genetic and environmental factors, and associated with psychological and medical comorbidities. It is a global phenomenon with a detrimental impact on families. Supplemental to conventional treatments care givers can consider using CAM.</p><p><strong>Eligibility criteria: </strong>Primary, secondary, and gray literature sources considering the use of CAM for ASD will be included. Sources proposing the use of CAM for any condition other than ASD or discussing any therapy for ASD other than CAM will be excluded. Studies in all languages will be considered for inclusion, as will sources from the last decade (2015-2025).</p><p><strong>Methods: </strong>This scoping review will be conducted in line with the JBI scoping review framework and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A primary search of PubMed to identify keywords and phrases will be followed by subsequent searches of Emcare (Ovid), Nursing and Allied Health Premium (ProQuest), Scopus, and Google Scholar. The titles, abstracts, and full texts of identified sources will be screened for relevancy by 2 independent reviewers, with conflicts adjudicated by a third reviewer. Findings will be discussed in a narrative summary and illustrated using figures, tables, and a gap map.</p><p><strong>Review registration: </strong>OSF https://osf.io/c9j5n/overview.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cindy Stern, Chelsea Valenzuela, Ashley Whitehorn, Danielle Pollock, Sonia Minooee, Dilan Arun Gohil, Zheng Zhu, Pamela Kirkpatrick, Ricardo Loureiro, Ellen Davies, Daniela Cardoso, Zachary Munn, Judith Carrier, Dawid Pieper, Kay Cooper, Romy Menghao Jia, Heather Loveday, Priya Martin, Susan Salmond, Kelli Borges Dos Santos, Nahal Habibi, Lucylynn Lizarondo
<p><strong>Objective: </strong>The objective of this scoping review was to map the range of methodologies and methods used to undertake evidence synthesis aimed at determining barriers and/or enablers in health care, and to inform further research relevant to synthesis methodology in this area.</p><p><strong>Introduction: </strong>Questions related to identifying and exploring barriers and/or enablers within health care are becoming increasingly popular. Currently, there are multiple approaches to synthesizing this evidence, and it is unclear whether a more consistent approach is warranted.</p><p><strong>Eligibility criteria: </strong>Evidence synthesis on barriers and/or enablers (facilitators) that included interest-holders at different levels of the health system were considered. Evidence synthesis projects had to include primary research studies and were published from 2010 to 2021. Literature reviews, narrative reviews, and umbrella reviews were excluded, as were reviews published in languages other than English.</p><p><strong>Methods: </strong>This scoping review followed JBI methodology and was based on a published a priori protocol and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A 3-step search strategy using a combination of key terms and index headings was undertaken in October 2021 via the following databases/resources: PubMed, Embase, CINAHL (EBSCOhost), PsycINFO (Ovid), Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, and EPPI-Centre Systematic Reviews. An extensive piloting process for screening and selection, and data extraction was undertaken due to the large number of reviewers involved. All records were screened independently by 2 reviewers, and any disagreements were resolved through either a third reviewer or discussion with a panel of reviewers. Extraction was undertaken using a customized form, and data were analyzed using descriptive statistics. Data are presented via tables, figures, a word cloud, and an infographic, supplemented with a narrative synthesis.</p><p><strong>Results: </strong>Following completion of the search, 22,308 records were screened and 774 reviews were included in the scoping review. Systematic reviews were the most commonly used methodology (68%) to synthesize barrier and/or enabler questions. Reviews often included diverse types of evidence and involved an assessment of methodological quality (70%). Findings related to barriers and/or enablers were usually grouped and organized into categories, often by thematic methods (33%) or a narrative approach (20%). Incongruencies related to nomenclature, missing information, and methods used were evident across the large dataset.</p><p><strong>Conclusions: </strong>A variety of methodological approaches are being followed to undertake reviews focused on barriers and/or enablers in health care. The current state of the literature indicates that most aut
{"title":"Evidence synthesis methodology for questions relating to barriers and enablers in health care: a scoping review.","authors":"Cindy Stern, Chelsea Valenzuela, Ashley Whitehorn, Danielle Pollock, Sonia Minooee, Dilan Arun Gohil, Zheng Zhu, Pamela Kirkpatrick, Ricardo Loureiro, Ellen Davies, Daniela Cardoso, Zachary Munn, Judith Carrier, Dawid Pieper, Kay Cooper, Romy Menghao Jia, Heather Loveday, Priya Martin, Susan Salmond, Kelli Borges Dos Santos, Nahal Habibi, Lucylynn Lizarondo","doi":"10.11124/JBIES-25-00265","DOIUrl":"https://doi.org/10.11124/JBIES-25-00265","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this scoping review was to map the range of methodologies and methods used to undertake evidence synthesis aimed at determining barriers and/or enablers in health care, and to inform further research relevant to synthesis methodology in this area.</p><p><strong>Introduction: </strong>Questions related to identifying and exploring barriers and/or enablers within health care are becoming increasingly popular. Currently, there are multiple approaches to synthesizing this evidence, and it is unclear whether a more consistent approach is warranted.</p><p><strong>Eligibility criteria: </strong>Evidence synthesis on barriers and/or enablers (facilitators) that included interest-holders at different levels of the health system were considered. Evidence synthesis projects had to include primary research studies and were published from 2010 to 2021. Literature reviews, narrative reviews, and umbrella reviews were excluded, as were reviews published in languages other than English.</p><p><strong>Methods: </strong>This scoping review followed JBI methodology and was based on a published a priori protocol and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A 3-step search strategy using a combination of key terms and index headings was undertaken in October 2021 via the following databases/resources: PubMed, Embase, CINAHL (EBSCOhost), PsycINFO (Ovid), Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, and EPPI-Centre Systematic Reviews. An extensive piloting process for screening and selection, and data extraction was undertaken due to the large number of reviewers involved. All records were screened independently by 2 reviewers, and any disagreements were resolved through either a third reviewer or discussion with a panel of reviewers. Extraction was undertaken using a customized form, and data were analyzed using descriptive statistics. Data are presented via tables, figures, a word cloud, and an infographic, supplemented with a narrative synthesis.</p><p><strong>Results: </strong>Following completion of the search, 22,308 records were screened and 774 reviews were included in the scoping review. Systematic reviews were the most commonly used methodology (68%) to synthesize barrier and/or enabler questions. Reviews often included diverse types of evidence and involved an assessment of methodological quality (70%). Findings related to barriers and/or enablers were usually grouped and organized into categories, often by thematic methods (33%) or a narrative approach (20%). Incongruencies related to nomenclature, missing information, and methods used were evident across the large dataset.</p><p><strong>Conclusions: </strong>A variety of methodological approaches are being followed to undertake reviews focused on barriers and/or enablers in health care. The current state of the literature indicates that most aut","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hector R Martinez, Misael Salazar-Alejo, Angélica Navarro-Serment, Ana Ballesteros-Suarez, Ryan A Luna-Fernández, Mario Benvenutti-Regato, Rogelio Flores-Salcido, Jose A Moran-Guerrero, Luis E Perez-Martinez, Emiliano Barajas-De-Leon, Pablo J Ávalos-Montes, Jose A Figueroa-Sanchez
Objective: This scoping review aims to map the existing evidence on Galassi III arachnoid cysts and identify knowledge gaps in the current literature.
Introduction: Galassi III arachnoid cysts are rare intracranial lesions characterized by significant midline displacement and associated with space-occupying effects. Despite their rarity, they have higher intervention rates than other types, yet optimal management remains unclear. Understanding their prevalence, pathophysiology, clinical characteristics, natural history, management strategies, and outcomes is critical for enhancing research on evidence-based management strategies aimed to improve patient care.
Eligibility criteria: This review will include clinical studies and review articles investigating patients with Galassi III arachnoid cysts. Studies should address the prevalence, pathophysiology, physical characteristics, natural history, presenting symptoms, treatment strategies, and/or outcomes associated with Galassi III arachnoid cysts. Studies published in English or Spanish will be included.
Methods: This scoping review will follow JBI methodology and will be reported according to PRISMA-ScR guidelines. A comprehensive search will be conducted in the PubMed, Scopus, and Web of Science Core Collection databases using a structured electronic search strategy developed in collaboration with a research librarian. Gray literature will be incorporated by searching clinical trial registries for studies involving patients with Galassi III arachnoid cysts. No publication date restrictions will be applied. The selection process will involve 3 steps, and Relevant data from included studies will be extracted using a standardized form. Quantitative and qualitative methods will be employed to synthesize the data. Results will be presented in graphic, tabular, and narrative formats.
目的:本综述旨在绘制关于Galassi III型蛛网膜囊肿的现有证据,并确定当前文献中的知识空白。Galassi III型蛛网膜囊肿是一种罕见的颅内病变,其特征是明显的中线移位,并伴有占位作用。尽管罕见,但其干预率高于其他类型,但最佳管理尚不清楚。了解其患病率、病理生理学、临床特征、自然病史、管理策略和结果对于加强旨在改善患者护理的循证管理策略的研究至关重要。入选标准:本综述将包括Galassi III型蛛网膜囊肿患者的临床研究和综述文章。研究应涉及与Galassi III型蛛网膜囊肿相关的患病率、病理生理学、生理特征、自然史、表现症状、治疗策略和/或结果。以英语或西班牙语发表的研究将包括在内。方法:本次范围审查将遵循JBI方法,并根据PRISMA-ScR指南进行报告。综合搜索将在PubMed、Scopus和Web of Science核心数据库中进行,使用与研究馆员合作开发的结构化电子搜索策略。灰色文献将通过检索涉及Galassi III型蛛网膜囊肿患者的临床试验注册来纳入。不受出版日期限制。选择过程将包括3个步骤,从纳入的研究中提取相关数据将使用标准化表格。将采用定量和定性相结合的方法对数据进行综合。结果将以图形、表格和叙述格式呈现。评审注册:OSF https://osf.io/EVBQK/overview。
{"title":"Characteristics, pathophysiology, and management of Galassi III arachnoid cysts: a scoping review protocol.","authors":"Hector R Martinez, Misael Salazar-Alejo, Angélica Navarro-Serment, Ana Ballesteros-Suarez, Ryan A Luna-Fernández, Mario Benvenutti-Regato, Rogelio Flores-Salcido, Jose A Moran-Guerrero, Luis E Perez-Martinez, Emiliano Barajas-De-Leon, Pablo J Ávalos-Montes, Jose A Figueroa-Sanchez","doi":"10.11124/JBIES-25-00115","DOIUrl":"https://doi.org/10.11124/JBIES-25-00115","url":null,"abstract":"<p><strong>Objective: </strong>This scoping review aims to map the existing evidence on Galassi III arachnoid cysts and identify knowledge gaps in the current literature.</p><p><strong>Introduction: </strong>Galassi III arachnoid cysts are rare intracranial lesions characterized by significant midline displacement and associated with space-occupying effects. Despite their rarity, they have higher intervention rates than other types, yet optimal management remains unclear. Understanding their prevalence, pathophysiology, clinical characteristics, natural history, management strategies, and outcomes is critical for enhancing research on evidence-based management strategies aimed to improve patient care.</p><p><strong>Eligibility criteria: </strong>This review will include clinical studies and review articles investigating patients with Galassi III arachnoid cysts. Studies should address the prevalence, pathophysiology, physical characteristics, natural history, presenting symptoms, treatment strategies, and/or outcomes associated with Galassi III arachnoid cysts. Studies published in English or Spanish will be included.</p><p><strong>Methods: </strong>This scoping review will follow JBI methodology and will be reported according to PRISMA-ScR guidelines. A comprehensive search will be conducted in the PubMed, Scopus, and Web of Science Core Collection databases using a structured electronic search strategy developed in collaboration with a research librarian. Gray literature will be incorporated by searching clinical trial registries for studies involving patients with Galassi III arachnoid cysts. No publication date restrictions will be applied. The selection process will involve 3 steps, and Relevant data from included studies will be extracted using a standardized form. Quantitative and qualitative methods will be employed to synthesize the data. Results will be presented in graphic, tabular, and narrative formats.</p><p><strong>Review registration: </strong>OSF https://osf.io/EVBQK/overview.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gillian Strudwick, Hwayeon Danielle Shin, Iman Kassam, Charlotte Pape, Terri Rodak, John Torous, Venkat Bhat, Jessica Kemp, Benjamin Rosen, Sean A Kidd
Objective: This scoping review aims to provide a comprehensive understanding of digital navigators in health care settings.
Introduction: Digital navigators have emerged to assist patients and clinicians in adopting and effectively using digital health technologies to achieve desired health outcomes. First introduced in the literature in 2015, this role has shown promise in selected health care settings, and more evidence is needed to formalize and scale this role across diverse clinical settings.
Inclusion criteria: This review will include both academic and gray literature that describe digital navigators in any health care setting for any patient-facing health care technology. There will be no country restrictions; however, due to the resources available to the research team, papers must be available in English.
Methods: This review will adhere to the JBI scoping review methodology. A comprehensive search will be conducted across the following databases: MEDLINE, PsycINFO, CINAHL, Embase, and Web of Science. Targeted Google searches and expert consultations will supplement the database searches. All search results will be assessed against the eligibility criteria, and relevant data will be extracted by 2 independent reviewers. The findings will be characterized using multiple frameworks and presented in the final scoping review report accompanied by a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
目的:本综述的目的是提供一个全面的了解数字导航在卫生保健设置。数字导航仪的出现是为了帮助患者和临床医生采用和有效地使用数字卫生技术来实现预期的健康结果。在2015年的文献中首次介绍了这一角色,在选定的医疗保健环境中显示出了希望,需要更多的证据来在不同的临床环境中正式确定和扩大这一角色。纳入标准:本综述将包括学术文献和灰色文献,这些文献描述了任何医疗保健环境中针对任何面向患者的医疗保健技术的数字导航仪。没有国家限制;然而,由于研究团队可用的资源,论文必须是英文的。方法:本次评审将遵循JBI范围评审方法。综合搜索将在以下数据库中进行:MEDLINE, PsycINFO, CINAHL, Embase和Web of Science。有针对性的谷歌搜索和专家咨询将补充数据库搜索。所有的搜索结果将根据资格标准进行评估,相关数据将由2名独立审稿人提取。研究结果将使用多种框架进行描述,并在最终的范围审查报告中提出,并附有系统审查和荟萃分析(PRISMA)流程图的首选报告项目。
{"title":"Understanding digital navigators in health care: a scoping review protocol.","authors":"Gillian Strudwick, Hwayeon Danielle Shin, Iman Kassam, Charlotte Pape, Terri Rodak, John Torous, Venkat Bhat, Jessica Kemp, Benjamin Rosen, Sean A Kidd","doi":"10.11124/JBIES-25-00167","DOIUrl":"https://doi.org/10.11124/JBIES-25-00167","url":null,"abstract":"<p><strong>Objective: </strong>This scoping review aims to provide a comprehensive understanding of digital navigators in health care settings.</p><p><strong>Introduction: </strong>Digital navigators have emerged to assist patients and clinicians in adopting and effectively using digital health technologies to achieve desired health outcomes. First introduced in the literature in 2015, this role has shown promise in selected health care settings, and more evidence is needed to formalize and scale this role across diverse clinical settings.</p><p><strong>Inclusion criteria: </strong>This review will include both academic and gray literature that describe digital navigators in any health care setting for any patient-facing health care technology. There will be no country restrictions; however, due to the resources available to the research team, papers must be available in English.</p><p><strong>Methods: </strong>This review will adhere to the JBI scoping review methodology. A comprehensive search will be conducted across the following databases: MEDLINE, PsycINFO, CINAHL, Embase, and Web of Science. Targeted Google searches and expert consultations will supplement the database searches. All search results will be assessed against the eligibility criteria, and relevant data will be extracted by 2 independent reviewers. The findings will be characterized using multiple frameworks and presented in the final scoping review report accompanied by a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The objective of this review is to synthesize and map the existing literature on the processes, barriers, facilitators, and challenges of pressure injury risk screening and care planning in hospitals using clinical information systems.
Introduction: International guidelines advocate a shift toward patient-centered care plans that integrate both risk screening and individualized prevention strategies. Simultaneously, health care systems are rapidly adopting digital technologies, including clinical information systems to support clinical practice. While studies have investigated risk screening and prevention strategies in hospital settings, no review has mapped these components within the context of clinical information systems. Investigating the processes, barriers, facilitators, and challenges of risk screening and care planning in hospitals using clinical information systems will inform the design of future patient-centered care plans, ultimately improving patient outcomes and reducing hospital-acquired pressure injuries.
Eligibility criteria: Studies involving clinicians of any background engaged in pressure injury risk screening and care planning within hospital settings that use clinical information systems will be included. Studies exploring risk screening and prevention strategies, either individually or as part of a broader care planning process, will be included. All study designs, except reviews, will be included.
Methods: Sources to be searched include MEDLINE (Ovid), Embase, CINAHL (EBSCOhost), Web of Science, and Scopus from January 2008 to May 2025. Title and abstracts will be screened by 2 independent reviewers, followed by full-text screening and extraction. Results will be presented in a matrix describing key features of the study related to the review's objectives.
目的:本综述的目的是综合和绘制现有文献关于医院使用临床信息系统进行压力损伤风险筛查和护理计划的过程、障碍、促进因素和挑战。导言:国际指南提倡转向以患者为中心的护理计划,将风险筛查和个性化预防策略结合起来。同时,卫生保健系统正在迅速采用数字技术,包括临床信息系统,以支持临床实践。虽然有研究调查了医院环境中的风险筛查和预防策略,但没有综述在临床信息系统的背景下绘制了这些组成部分。研究医院使用临床信息系统进行风险筛查和护理计划的过程、障碍、促进因素和挑战,将为未来以患者为中心的护理计划的设计提供信息,最终改善患者的治疗效果,减少医院获得性压力伤害。入选标准:在使用临床信息系统的医院环境中,涉及从事压力损伤风险筛查和护理计划的任何背景的临床医生的研究将包括在内。将包括探索风险筛查和预防策略的研究,无论是单独的还是作为更广泛的护理规划过程的一部分。所有的研究设计,除了回顾,将包括在内。方法:2008年1月至2025年5月检索的文献包括MEDLINE (Ovid)、Embase、CINAHL (EBSCOhost)、Web of Science和Scopus。题目和摘要将由2名独立审稿人进行筛选,然后进行全文筛选和摘录。结果将以矩阵形式呈现,描述与综述目标相关的研究的主要特征。评审注册:OSF https://osf.io/jrd29/overview。
{"title":"Pressure injury risk screening and care planning in hospitals using clinical information systems: a scoping review protocol.","authors":"Willoughby Hay, Rowena Forsyth, Melissa Baysari, Michelle Barakat-Johnson","doi":"10.11124/JBIES-25-00205","DOIUrl":"10.11124/JBIES-25-00205","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this review is to synthesize and map the existing literature on the processes, barriers, facilitators, and challenges of pressure injury risk screening and care planning in hospitals using clinical information systems.</p><p><strong>Introduction: </strong>International guidelines advocate a shift toward patient-centered care plans that integrate both risk screening and individualized prevention strategies. Simultaneously, health care systems are rapidly adopting digital technologies, including clinical information systems to support clinical practice. While studies have investigated risk screening and prevention strategies in hospital settings, no review has mapped these components within the context of clinical information systems. Investigating the processes, barriers, facilitators, and challenges of risk screening and care planning in hospitals using clinical information systems will inform the design of future patient-centered care plans, ultimately improving patient outcomes and reducing hospital-acquired pressure injuries.</p><p><strong>Eligibility criteria: </strong>Studies involving clinicians of any background engaged in pressure injury risk screening and care planning within hospital settings that use clinical information systems will be included. Studies exploring risk screening and prevention strategies, either individually or as part of a broader care planning process, will be included. All study designs, except reviews, will be included.</p><p><strong>Methods: </strong>Sources to be searched include MEDLINE (Ovid), Embase, CINAHL (EBSCOhost), Web of Science, and Scopus from January 2008 to May 2025. Title and abstracts will be screened by 2 independent reviewers, followed by full-text screening and extraction. Results will be presented in a matrix describing key features of the study related to the review's objectives.</p><p><strong>Review registration: </strong>OSF https://osf.io/jrd29/overview.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}